MedPath

Smoking cessation for severe mental ill health trial

Not Applicable
Completed
Conditions
Tobacco addiction in severe mental ill health
Mental and Behavioural Disorders
Mental and behavioural disorders due to use of tobacco
Registration Number
ISRCTN72955454
Lead Sponsor
niversity of York
Brief Summary

2017 Protocol article in https://www.ncbi.nlm.nih.gov/pubmed/28126031 protocol (added 30/01/2017) 2018 Results article in https://www.ncbi.nlm.nih.gov/pubmed/29351792 results (added 29/03/2019) 2019 Results article in https://www.ncbi.nlm.nih.gov/pubmed/30975539 results (added 15/04/2019) 2019 Results article in https://www.ncbi.nlm.nih.gov/pubmed/31549622 results (added 27/09/2019) 2020 Results article in https://pubmed.ncbi.nlm.nih.gov/33054882/ results (added 22/10/2020) 2020 Results article in https://pubmed.ncbi.nlm.nih.gov/32388396/ cross-sectional study results (added 17/05/2021) 2019 Other publications in https://pubmed.ncbi.nlm.nih.gov/32742637/ SWAT results (added 15/02/2023)

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
526
Inclusion Criteria

As of 14/10/2016:
Adults of all ages (either sex) with a documented diagnosis of severe and enduring mental illness (schizophrenia or delusional/psychotic illness or bipolar disorder) who currently smoke at least 5 tobacco cigarettes per day and are interested in cutting down or quitting smoking

Initial:
Adults of all ages (either sex) with severe and enduring mental illness who currently smoke and are interested in cutting down or quitting smoking

Exclusion Criteria

1. Patients with alcohol dependence
2. Patients with co-morbid drug addiction
3. Non-English speaking

Added 14/10/2016:
1. Lack of capacity to consent
2. Pregnant or breastfeeding
3. Currently receiving advice from a stop smoking adviser

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Self-reported smoking cessation at 12 months post-recruitment verified by carbon monoxide breath measurement
Secondary Outcome Measures
NameTimeMethod
<br> All secondary outcomes will be measured at the 6 and 12 month timepoints:<br> 1. Reduction in the number of cigarettes smoked per day (self-report)<br> 2. Dependence on smoking as assessed by the Fagerstrom Nicotine Dependence Questionnaire<br> 3. Level of motivation as assessed by the Motivation to quit questionnaire<br> 4. Patient Health Questionnaire 9 (PHQ-9)<br> 5. Health Related Quality of Life (SF-12)<br> 6. EuroQol EQ-5D<br><br> Added 24/10/2016:<br> 7. BMI<br> 8. Health service use, collected via a bespoke questionnaire<br><br> Added 28/08/2018:<br> 9. Anxiety measured using GAD-7 at baseline, 6 and 12 months<br>
© Copyright 2025. All Rights Reserved by MedPath